SB 876

  • Florida Senate Bill
  • 2025 Regular Session
  • Introduced in Senate Mar 04, 2025
  • Senate
  • House
  • Governor

Chimeric Antigen Receptor T-cell Therapy

Bill Subjects

Insurance

Abstract

Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.

Bill Sponsors (1)

Votes


No votes to display

Actions


Jun 16, 2025

Senate

Died in Banking and Insurance

May 03, 2025

Senate

Indefinitely postponed and withdrawn from consideration

Mar 04, 2025

Senate

Introduced

Feb 28, 2025

Senate

Referred to Banking and Insurance; Judiciary; Rules

Feb 19, 2025

Senate

Filed

Bill Text

Bill Text Versions Format
S 876 Filed PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Florida Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.